Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.61 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | ANPEP | P15144 | 1/20 | 0.50 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.50 |
| ▸ | BHMT | Q93088 | 10/20 | 0.49 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.49 |
| ▸ | FNTA | P49354 | 2/20 | 0.47 |
| ▸ | FNTB | P49356 | 2/20 | 0.47 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.47 |
| ▸ | NOS2 | P35228 | 2/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Racemethionine SCHEMBL561474 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Methionine SCHEMBL6157104 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Racemethionine SCHEMBL28318256 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Methionine SCHEMBL4623092 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Racemethionine SCHEMBL4623089 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Racemethionine SCHEMBL23924425 | 1.00 | PTGS1 (0.61) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Methionine SCHEMBL18130269 | 0.98 | PTGS1 (0.59) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Racemethionine SCHEMBL28273285 | 0.98 | PTGS1 (0.59) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Methionine SCHEMBL8450225 | 0.95 | PTGS1 (0.55) | PTGS1SLC7A11RNPEPANPEPENPEP | |
| Racemethionine SCHEMBL8450224 | 0.95 | PTGS1 (0.55) | PTGS1SLC7A11RNPEPANPEPENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212623-A1 | L-METHIONINE PRODUCING MICROORGANISM TO WHICH PROTEIN ENCODED BY FOREIGN METZ GENE IS INTRODUCED AND METHOD FOR PRODUCING L-METHIONINE USING SAME | CJ CHEILJEDANG CORPORATION (KR) | 2023-07-06 | — | — | US | claimed |
| CN-114729379-A | L-methionine-producing microorganism introduced with exogenous metZ gene-encoding protein and method for producing L-methionine using the same | CJ第一制糖株式会社 | 2022-07-08 | — | — | CN | claimed |
| WO-2021085999-A1 | L-METHIONINE PRODUCING MICROORGANISM TO WHICH PROTEIN ENCODED BY FOREIGN METZ GENE IS INTRODUCED AND METHOD FOR PRODUCING L-METHIONINE USING SAME | 씨제이제일제당 (주) | 2021-05-06 | — | — | WO | claimed |
| EP-3544992-A1 | G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS | The Regents of The University of California (US) | 2019-10-02 | — | — | EP | claimed |
| EP-3197479-B1 | ANTIMICROBIAL PEPTIDES | OMNIX MEDICAL LTD (IL) | 2019-06-26 | — | — | EP | claimed |
| WO-2019118370-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PRODUCING FLOCCULENT MATERIALS FOR SPECIAL EFFECTS | XOTRAMORPHIC, LLC (US) | 2019-06-20 | — | — | WO | claimed |
| EP-3496740-A1 | A COMBINATION OF ANTIMICROBIAL PEPTIDES AND ANTIBIOTIC DRUGS FOR TREATING DISEASES | Omnix Medical Ltd. (IL) | 2019-06-19 | — | — | EP | claimed |
| US-20190177379-A1 | COMBINATION OF ANTIMICROBIAL PEPTIDES AND ANTIBIOTIC DRUGS FOR TREATING DISEASES | OMNIX MEDICAL LTD. (IL) | 2019-06-13 | — | — | US | claimed |
| WO-2018098262-A1 | G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-05-31 | — | — | WO | claimed |
| WO-2018029676-A1 | A COMBINATION OF ANTIMICROBIAL PEPTIDES AND ANTIBIOTIC DRUGS FOR TREATING DISEASES | OMNIX MEDICAL LTD. (IL) | 2018-02-15 | — | — | WO | claimed |
| US-5602119-A | TREATMENT OF HIV AND AIDS | G. D. SEARLE & CO. | 1997-02-11 | — | — | US | claimed |
| EP-0666841-B1 | SUCCINOYLAMINO HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | SEARLE & CO (US) | 1997-01-22 | — | — | EP | claimed |
| EP-0666841-A1 | SUCCINOYLAMINO HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS. | SEARLE & CO (US) | 1995-08-16 | — | — | EP | claimed |
| WO-1994010133-A1 | SUCCINOYLAMINO HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1994-05-11 | — | — | WO | claimed |
| US-5151521-A | 1-aminoethyl phosphonic acid derivatives | MERCK & CO., INC. (US) | 1992-09-29 | — | — | US | claimed |
| US-4976957-A | EXTRACTION FROM BROKEN LYMPHOMA TUMOR CELLS, THEN ISOLATION BY THIN LAYER GEL CHROMATOGRAPHY | BOGOCH SAMUEL (US) | 1990-12-11 | — | — | US | claimed |
| EP-0175871-B1 | PROCESS FOR IMPROVING OR MODIFYING THE TASTE AND AROMA OF CITRUS FRUIT COMPOSITIONS | FIRMENICH SA (CH) | 1988-03-23 | — | — | EP | claimed |
| EP-0175871-A1 | Process for improving or modifying the taste and aroma of citrus fruit compositions | FIRMENICH SA (CH) | 1986-04-02 | — | — | EP | claimed |
| US-4486538-A | ANTI-MALIGNIN ANTIBODIES | BOGOCH SAMUEL | 1984-12-04 | — | — | US | claimed |
| US-4298590-A | PREFERENTIAL BINDING OF RECOGNIN TO CANCER CELLS | BOGOCH SAMUEL | 1981-11-03 | — | — | US | claimed |